Today’s Top Stories In Diabetes News!

Oral basal insulin shows promise in type 2 diabetes

An oral basal insulin formulation has produced glycemic control equivalent to that of injected insulin glargine in insulin-naïve type 2 diabetes patients.

Results from a phase 2a Novo Nordisk–sponsored feasibility study were presented on June 13 here at the American Diabetes Association (ADA) 2017 Scientific Sessions by Leona Plum-Mörschel, PD, chief executive officer of Profil Mainz, Germany.

The abstract was among just eight selected for presentation in the ADA President’s Oral Session on the last day of the conference. (read more)


Does a new tattoo ink allow people with diabetes to monitor their blood sugar levels?

A viral meme describes a promising research project at MIT and Harvard, but so far it has only been tested on the skin of a dead pig.

Interstitial fluid is a layer of fluid that surrounds cells within the body. Measuring the level of glucose (blood sugar) in the fluid is an important way for people with diabetes to keep their blood sugar at an appropriate level and avoid diabetic shock (severe hypoglycemia). (read more)

Exercise, CBT, diminish diabetes-associated depression

Exercise and cognitive behavioral therapy (CBT), individually or in combination, can significantly relieve depression in people with type 2 diabetes, according to new findings presented at the recent American Diabetes Association (ADA) 2017 Scientific Sessions.

The results also demonstrate the feasibility of involving local community practitioners to help patients in rural areas who might not otherwise have access to comprehensive self-care programs, said Mary de Groot, PhD, associate professor of medicine and acting director of the Diabetes Translational Research Center, Indiana University School of Medicine, Indianapolis. (read more)